News
The FDA has granted de novo marketing authorisation to TISSIUM’s COAPTIUM CONNECT, representing the first atraumatic option ...
The infusion pump market is set to reach $2.2bn in 2034, according to GlobalData.
E2 has completed enrolment of subjects in the pivotal cohort of its ENGULF trial, involving the Hēlo PE Thrombectomy System.
ITM and Swiss-based Debiopharm have announced the imaging of the first subject in a new study arm (Part D) of the Phase I/II ...
Johnson & Johnson (J&J) has launched a new daily disposable contact lens for individuals with astigmatism and presbyopia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results